1. Field of the Invention
The present invention is directed to providing non-invasive transdermal electrical stimulation and, in particular, providing non-invasive transdermal electrical stimulation at an adjustable position on a head for the treatment of headaches.
2. Description of Related Art
Chronic headaches cause debilitating pain that significantly hampers one's lifestyle. Conventional treatment for intractable chronic headaches, especially migraines, include pharmacological agents, magnetic neurostimulation and/or electrical neurostimulation. Pharamcological agents typically have undesirable adverse side effects such as nausea, dizziness, sleepiness, fatigue and muscle weakness.
As an alternative to pharmacological agents, non-invasive methods such as transcranial magnetic neurostimulation have also been utilized in the treatment of migraine headaches. U.S. Patent Application Publication No. 2006/0047316 discloses a System for the Treatment of Migraine Headaches employing a magnetic pulse system including a head unit connected to a table unit by a connecting cable. The head unit includes a conducting wire coil through which an electrical current is used to create a high intensity, short duration, magnetic pulse. When the head unit is placed next to the scalp, the strong magnetic field penetrates the skull producing an electrical current that stimulates the cerebral cortex. The accompanying circuitry and instrumentation undesirably make this conventional device bulky. To reduce the bulkiness associated with external stimulation devices, stimulation devices of significantly reduced size have been implanted in the body. Several such known techniques for the treatment of headaches using an implantable stimulator are discussed in the following issued U.S. Patents and U.S. Published Patent Applications: U.S. Pat. No. 7,711,432; U.S. Pat. No. 6,735,475; 2011/0060382; 2010/0204749; 2006/0235484; 2006/0206165; 2006/0206166; 2006/0064140; 2006/0047325. However, implantation is an invasive surgical procedure that requires the leads to be placed subcutaneously. As a result such implanted devices suffer from the following potential drawbacks: lead migration, painful stimulation and possible infection at the site in which the leads pass subcutaneously beneath the skin. Yet another disadvantage is revision surgery required to replace the battery associated with the implantable pulse generators.
It would therefore be desirable to develop a non-invasive transcutaneous electrical stimulation patch for eliciting paraesthesis and/or reducing pain associated with intractible chronic headaches that overcomes the aforementioned disadvantages associated with conventional stimulation systems.
One aspect of the present invention is directed to a device for providing transdermal electrical stimulation at an adjustable position on a bead. The device includes a supporting member ergonomically shaped and configured to be fixedly supported about an anatomical body part; the supporting member being adjustably positionable in only two directions substantially perpendicular to one another. No electrical stimulation is provided by the supporting member.
Another aspect of the present invention is directed to a device for providing transdermal electrical stimulation at an adjustable position on a head that includes at least one pair of electrodes for producing the transdermal electrical stimulation. The electrodes are mounted to a securing member shaped and configured to be releasably securable only about a plurality of strands of hair at a predetermined fixed orientation without being secured about any anatomical body part.
The foregoing, and other features of the present invention will be more readily apparent from the following detailed description and drawings of illustrative embodiments of the invention wherein like reference numbers refer to similar elements throughout the several views and in which:
The patches may be oriented in any direction that induces paresthesia in the occipital nerve or one of its branches. Several exemplary orientations are illustrated in
Proper positioning of the transcutaneous electrical stimulation patch on the back of the patient's head in order to transcutaneously stimulate the occipital nerve or its branches may be realized by using a two dimensional (x, y) matrix or grid pattern projected onto the scalp/cervical/neck area of the patient as depicted in
A method for optimizing placement of a transcutaneous nerve stimulation device begins with identifying a plurality of test sites on a patient's head. Each block of the grid is a potential test site. The patch is placed at a selected location (xi, yj) or a block of the grid and a test stimulation current signal is applied to elicit paresthesia and/or reduction in pain. An indicator of reduction in pain or paresthesia in response to the applied transcutaneous test current at the selected one of the plural test sites is recorded. The patch is then positioned at a new selected location (xi, yj) or block of the grid and once again a test stimulation signal is applied. This procedure is repeated until the position (e.g., location or block) is identified in which the stimulating device elicits an optimum paresthesia and/or reduction in pain.
In a particular application of the method in accordance with the preceding paragraph, the electrodes in
Releasable liners are removed from the stimulating electrodes to expose a releasable adhesive layer. A first electrode is positioned so that its center is substantially aligned over a midpoint of the superior nuchal line. A second electrode may be placed either beneath the first electrode or on the contra lateral side similar to the first electrode. Wire leads are snapped onto connector nipples associated with the electrodes. A negative lead is connected to the first electrode. The signal generator is powered on and an opposite end of the negative lead is connected to the signal generator. An initial voltage is preferably preprogrammed into the device. By way of example, the initial preprogrammed voltage is approximately 6 volts. Thereafter, the voltage is increased in predetermined steps or increments to deliver a signal of a predetermined average current (e.g., preferably approximately 70 mA average current). With each increment in voltage, the patient reports any discomfort. In the presence of any discomfort, the voltage is decremented in predetermined intervals (e.g., preferably approximately ½ volt steps) until the patient is no longer experiencing any discomfort. The following events are recorded: (i) stimulation voltage at which the subject first reports sensation (hereinafter referred to as a “perception threshold”); (ii) stimulation voltage at which the subject reports comfortable sensation (hereinafter referred to as “optimal stimulation”); (iii) maximum tolerable stimulation voltage when discomfort is experienced (hereinafter referred to as “discomfort threshold”); and (iv) x, y coordinates in the grid of sensation in the paresthesia map. The leads are disconnected from the signal generator which is reset to several different frequencies and the steps above repeated. Once this process has been completed for the first electrode, the process is repeated for the second electrode
The grids in accordance with the embodiments in
A first exemplary adjustable positioning head electrical stimulation device 300, as depicted in
Ear clip adjustable positioning headset device 300, as shown in
An alternative configuration of the adjustable positioning headset device 400 depicted in
Other configurations of the adjustable positioning headset devices supported by other body parts are contemplated that permit adjustment of positioning of the stimulation patch in at least one direction (e.g., adjustment of the stimulation patch relative to the auxiliary arm and/or adjustment of the auxiliary arm relative to the main arm), preferably two dimensional adjustment independently of one another. Regardless of the configuration, it is preferred to design the adjustable positioning headset device so as to be aesthetically and cosmetically inconspicuous.
The adjustable positioning head electrical transdermal stimulation devices described in the preceding paragraphs may be used to vary the position of the transdermal electrical stimulation patch on the head based on the induced paresthesia resulting from a test stimulation signal generated at a particular location similar to that of the projected grid pattern.
The aforementioned adjustable positioning head electrical transdermal stimulation devices have all been secured to an anatomical body part, e.g., about the ear or about the neck. Such devices are advantageously releasably securable to the body without having to shave all or a portion of the scalp while eliminating the need for adhesives. Alternative mechanical devices are contemplated that, rather than being supported by an anatomical body part, are releasably securable directly about a plurality of hair stands at a desired fixed, stationary location on the back of the patient's head. Several exemplary embodiments are shown and described herein in which the transdermal electrical stimulation device is releasably attachable only to one or more strands of hair on the head without the use of an adhesive or supported by an anatomical body part.
In a first embodiment illustrated in
A second exemplary embodiment is depicted in
Still another alternative hair securing mechanism is a hair clip 900 shown in
A barrette 1000 is depicted in
Other releasable hair securing mechanisms are contemplated and within the intended scope of the present invention provided that that are releasably securable about a plurality of hair strands and able to accommodate the electrodes and associated electronic circuitry for producing a desired electric field of sufficient are and strength to stimulate a target site on the head (e.g., stimulation of the occipital nerve).
Heretofore, the present invention has been shown and described as a neurostimulation device for treatment of chronic headaches by stimulating only the occipital nerve or one of its branches (ONS—occipital nerve stimulation) via one or more pairs of transdermal electrodes. However, ONS alone is limited to treatment of intractable occipital neuralgia and cervicogenic headaches associated with pain in the back of the head/neck while exhibiting reduced efficacy in response to front-temporal headaches (e.g., migraines, cluster headaches) associated with the front of the head. In such cases, localized stimulation of the occipital nerve or one of its branches alone has less than optimum impact on reducing or minimizing the front-temporal pain produced in the front of the head above the eyes. Localized stimulation of the occipital and trigeminal nerves and associated superficial branches in accordance with the present invention may be particularly well suited for the treatment of chronic headaches causing pain in the back as well as in the front of one's head. This alternative transcutaneous external electrical stimulator system in accordance with the present invention is illustrated in
Specifically,
One challenge associated with the stimulation of the ONS and/or TNS nerves is that these nerves are stimulated by relative low frequency signals, on the order of approximately 1 Hz-approximately 200 Hz. However, the scalp includes superficial layers such as: skin, fat, fibrous and dense connective tissue, and areolar connective tissue. Inherent impedance associated with the scalp hampers the stimulation signal within this frequency range from passing through body tissue. Skin impedance may be overcome by modulating the stimulation signal by a higher frequency carrier waveform signal preferably in the range of approximately 100 kHz-approximately 400 kHz, as described in detail in the commonly assigned U.S. Pat. No. 7,979,137 which is herein incorporated by reference in its entirety. The higher frequency carrier enables the lower frequency stimulation signal to bypass the impedance associated with the superficial (fat and connective tissue) layers of the scalp while the envelope of the lower frequency stimulation signal initiates an action potential that stimulates the occipital nerves and/or trigeminal nerves or its associated branches.
The modulated signal 1406 is provided to an appropriate surface electrode 1310, such as DURA-STICK Self Adhesive Electrodes from Chattanooga Group, Inc. of Hixson, Tenn., that applies the modulated waveform directly to the skin. The use of the modulated signal enables transmission of the waveform through tissue due to the relatively high frequency nature of the first waveform, yet allows it to be detected (and responded to) by the occipital and/or trigeminal nerve and associated branches due to the relatively low frequency envelope of the modulated signal.
Stimulation of the occipital and trigeminal nerves may be continuous or intermittent in the time domain. Several exemplary timing diagrams are depicted in
The duty cycle of each waveform is preferably adjustable for optimum therapeutic treatment and conserve energy. The stimulation circuit may be either voltage or current controlled.
Placement of the patches 500, 515 on the head to stimulate the ONS and TNS nerves, respectively, may be realized based on stimulation induced paresthesia using a grid (as described in detail above with respect to
In the illustrative examples, the amplitude of the respective ONS and TNS waveforms are substantially equal. It is contemplated and within the intended scope of the present invention for the amplitudes of the respective waveforms to differ from one another.
Thus, while there have been shown, described, and pointed out fundamental novel features of the invention as applied to a preferred embodiment thereof, it will be understood that various omissions, substitutions, and changes in the form and details of the devices illustrated, and in their operation, may be made by those skilled in the art without departing from the spirit and scope of the invention. For example, it is expressly intended that all combinations of those elements and/or steps that perform substantially the same function, in substantially the same way, to achieve the same results be within the scope of the invention. Substitutions of elements from one described embodiment to another are also fully intended and contemplated. It is also to be understood that the drawings are not necessarily drawn to scale, but that they are merely conceptual in nature. It is the intention, therefore, to be limited only as indicated by the scope of the claims appended hereto.
Every issued patent, pending patent application, publication, journal article, book or any other reference cited herein is each incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3620219 | Barker | Nov 1971 | A |
5569166 | Stone | Oct 1996 | A |
6132392 | Stone | Oct 2000 | A |
6275736 | Kuzma et al. | Aug 2001 | B1 |
6735475 | Whitehurst et al. | May 2004 | B1 |
6954668 | Cuozzo | Oct 2005 | B1 |
7089054 | Palti | Aug 2006 | B2 |
7155276 | Lamont | Dec 2006 | B2 |
7231256 | Wahlstrand et al. | Jun 2007 | B2 |
7277749 | Gordon et al. | Oct 2007 | B2 |
7499752 | Maschino et al. | Mar 2009 | B2 |
7610095 | Naisberg | Oct 2009 | B2 |
7613519 | Ridder | Nov 2009 | B2 |
7711432 | Thimineur et al. | May 2010 | B2 |
7769461 | Whitehurst et al. | Aug 2010 | B2 |
7844340 | Pawlowicz | Nov 2010 | B2 |
7853321 | Jaax et al. | Dec 2010 | B2 |
7979137 | Tracey et al. | Jul 2011 | B2 |
8000812 | Paolizzi et al. | Aug 2011 | B2 |
8041429 | Kirby | Oct 2011 | B2 |
20040243206 | Tadlock | Dec 2004 | A1 |
20050154419 | Whitehurst et al. | Jul 2005 | A1 |
20060004423 | Boveja et al. | Jan 2006 | A1 |
20060025387 | Hochman | Feb 2006 | A1 |
20060035914 | Hochman | Feb 2006 | A1 |
20060047316 | Fischell et al. | Mar 2006 | A1 |
20060047325 | Thimineur et al. | Mar 2006 | A1 |
20060064140 | Whitehurst et al. | Mar 2006 | A1 |
20060095088 | De Ridder | May 2006 | A1 |
20060111754 | Rezai et al. | May 2006 | A1 |
20060206165 | Jaax et al. | Sep 2006 | A1 |
20060206166 | Weiner | Sep 2006 | A1 |
20060235484 | Jaax et al. | Oct 2006 | A1 |
20080262566 | Jaax | Oct 2008 | A1 |
20090210028 | Rigaux et al. | Aug 2009 | A1 |
20100030299 | Covalin | Feb 2010 | A1 |
20100049277 | Wahlstrand et al. | Feb 2010 | A1 |
20100114191 | Newman | May 2010 | A1 |
20100152808 | Boggs | Jun 2010 | A1 |
20100204749 | Thimineur et al. | Aug 2010 | A1 |
20110060382 | Jaax et al. | Mar 2011 | A1 |
20110093033 | Nekhendzy | Apr 2011 | A1 |
20110106220 | DeGiorgio et al. | May 2011 | A1 |
20110112603 | DeGiorgio et al. | May 2011 | A1 |
20110184489 | Nicolelis et al. | Jul 2011 | A1 |
20110218589 | DeGiorgio et al. | Sep 2011 | A1 |
20110218590 | DeGiorgio et al. | Sep 2011 | A1 |
20110230701 | Simon et al. | Sep 2011 | A1 |
20110264167 | Poletto | Oct 2011 | A1 |
20110282129 | Rigaux | Nov 2011 | A1 |
Number | Date | Country |
---|---|---|
2092951 | Aug 2009 | EP |
2008128215 | Oct 2008 | WO |
2011044173 | Apr 2011 | WO |
2011044176 | Apr 2011 | WO |
2011044178 | Apr 2011 | WO |
2011044179 | Apr 2011 | WO |
Entry |
---|
Johnstone et al., “Occiptial Nerve Stimulation for the Treatment of Occipital Neuralgia—Eight Case Studies,” Neuromodulation, (2006) vol. 9, No. 1, pp. 41-47. |
Drummond et al., “Electrical Stimulation Decreases Neuralgic Pain After Trigeminal Deafferentation,” Cephalalgia (2008), vol. 28, pp. 782-785. |
Singla et al., “Role of Transcutaneous Electric Nerve Stimulation in the Management of Trigeminal Neuralgia,” J. of Neurosciences in Rural Practice (Jul.-Dec. 2011); vol. 2, No. 2, pp. 150-152. |
Cooper et al., “Establishment of a Temporomandibular Physiological State with Neuromuscular Orthosis Treatment Affects Reduction of TMD Symptoms in 313 Patients,” The Journal of Cranomandibular Practice, (Apr. 2008); vol. 26, No. 2, pp. 104-117. |
deCiccio, Vincenzo, “Central Syntropic Effects Elicited by Trigeminal Proprioceptive Equilibrium in Alzheimer's Disease: A case Report,” Journal of Medical Case Reports, (2012); vol. 6, No. 161, pp. 1-8. |
DeGiorgio et al., “Pilot Study of Trigeminal Nerve Stimulation (TNS) for Epilepsy: A Proof-of-Concept Trial,” Epilepsia, (2006); vol. 47, No. 7, pp. 1213-1215. |
Herman et al., “Using Transcutaneous Electrical Nerve Stimulation to Prevent Postoperative Pain,” JADA (May 2002); vol. 133, pp. 643-645. |
Mousavi et al., “Comparison Between Efficacy of Imipramine and Transcutaneous Electrical Nerve Stimulation in the Prophylaxis of Chronic Tension-Type Headache: A Randomized Controlled Clinical Trial,” J. Res. Med. Sci. (Jul. 2011); vol. 16, No. 7, pp. 923-927. |
Yameen et al., “Efficacy of Transcutaneous Electrical Nerve Stimulation and its different modes in Patients With Trigeminal Neuralgia,” J. Pak. Med. Assoc. (May 2011); vol. 61, No. 5, pp. 437-439. |
Tayeb et al., “Successful! Treatment of Nummular Headache With TENS,” Cephalalgia (2008); vol. 28, pp. 897-898. |
Allais et al., “Non-Pharmacological Approaches to Chronic Headaches: Transcutaneous Electrical Nerve Stimulation, Laser Therapy and Acupuncture in Transformed Migraine Treatment,” Neurol Sci. (2003); vol. 24, pp. S138-S142. |
Rushton, D. N., “Electrical Stimulation in the Treatment of Pain,” Disability and Rehabilitation (2002); vol. 24, No. 8, pp. 407-415. |
Johnson, Mark I., “Transcutaneous Electrical Nerve Stimulation (TENS) and TENS-like devices: do they provide pain relief?”, Pain Reviews (2001); vol. 8, pp. 121-158. |
Thorsen et al., “Trigeminal Neuralgia: Sudden and Long-Term Remission With Transcutaneous Electrical Nerve Stimulation,” Journal of Manipulative & Physiological Therapeutics (Jul.-Aug. 1997); vol. 20, No. 6, pp. 415-419. |
Narouze et al., “Supraorbital nerve Electric Stimulation for the Treatment of Intractable Chronic Cluster Headache: A Case Report,” Headache (Jul./Aug. 2000), pp. 1100-1102. |
Young, Ronald F. M.D., “Electrical stimulation of the Trigeminal Nerve Root for the Treatment of Chronic Facial Pain,” J. Neurosurg. (1995), vol. 83, pp. 72-78. |
Paemeleire et al., “Occiptial Nerve Stimulation for Headache Disorders,” Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, (Apr. 2010), vol. 7, pp. 213-219. |
Magis et al., “Occipital nerve Stimulation for Drug-Resistant Chronic Cluster Headache: A Prospective Pilot Study,” Lancet Neurol. (2007); vol. 6, pp. 314-321. |
Bartsch et al., “Neurostimulation Approaches to Primary Headache Disorders,” Current Opinion in Neurology, (2009) vol. 22, pp. 262-268. |
Burns et al., “Treatment of Medically Intractable Cluster Headache by Occipital Nerve Stimulation: Long-Term Follow-Up of Eight Patients,” The Lancet (Mar. 31, 2007); vol. 369, pp. 1099-1106. |
Saper et al., “Occiptial Nerve Stimulation for the Treatment of Intractable Chronic Migraine Headache: ONSTIM Feasibility Study,” Cephalalgia, (2010); vol. 31, No. 3, pp. 271-285. |
Schwedt et al., “Occiptial Nerve Stimulation for Chronic Cluster Headache and Hemicrania Continua: Pain Relief and Persistence of Autonomic Features,” Cephalalgia (2006); vol. 26, pp. 1025-1027. |
Trentmand et al., “Stimulation Ranges, Usage Ranges, and Paresthesia Mapping During Occipital Nerve Stimulation,” Neuromodulation: Technology at the Neural Interface, (2008); vol. 11, No. 1, pp. 56-61. |
Number | Date | Country | |
---|---|---|---|
20140277324 A1 | Sep 2014 | US |